探索奎尔丁在癌症治疗中的治疗潜力:准长非编码RNAs
Farhad Sheikhnia1, Ahmad Fazilat2, Vahid Rashidi3
1Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran; Department of Clinical Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Pathology, research and practice
|June 18, 2024
概括
Quercetin 是一种天然化合物,通过调节长非编码RNAs (lncRNAs) 在癌症治疗中表现有前途. 它抑制促进癌症的lncRNAs并增强抑制瘤的瘤,提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 全球癌症发病率需要新的药理干预措施.
- 长非编码RNAs (lncRNAs) 是癌症发展的关键调节者,影响扩散,亡,转移,新陈代谢和耐药性.
- 奎尔是一种天然的化合物,具有显著的抗癌特性,包括抑制癌细胞生长和诱导亡.
研究的目的:
- 审查Quercetin在癌症治疗中的治疗潜力,重点关注其与lncRNAs的相互作用.
- 探索瑞如何调节lncRNA的表达和功能,以实现抗癌效应.
- 讨论奎尔素的化学预防作用和未来的研究方向.
主要方法:
- 关于奎尔丁, lncRNAs 和癌症的综合文献综述.
- 在调节致癌和抑制瘤的lncRNAs时分析奎尔丁的机制.
- 综合关于奎尔素抗癌和化疗预防潜力的当前知识.
主要成果:
- 奎瑞抑制了促进癌症发展和进展的致癌性 lncRNAs.
- 奎尔塞丁增强抑制瘤的lncRNAs,抑制癌症的生长和扩散.
- 奎尔丁显示出作为抗癌化学预防剂的潜力.
结论:
- 奎尔在癌症治疗中通过lncRNA调制表现出有前途的治疗潜力.
- 需要进一步的机制研究和策略来改善奎尔丁的生物可用性和向特异性.
- 奎尔代表了癌症治疗中潜在的新疗法策略.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Types of RNA
63.5K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


